Hinge Health (HNGE) Current Deferred Revenue (2024 - 2026)

Hinge Health (HNGE) has 3 years of Current Deferred Revenue data on file, last reported at $340.8 million in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue rose 56.8% year-over-year to $340.8 million; the trailing twelve-month figure through Mar 2026 stood at $340.8 million (up 56.8% YoY), and the FY2025 full-year result was $300.9 million, up 38.24% from the prior year.
• Current Deferred Revenue advanced to $340.8 million in Q1 2026, from $300.9 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $340.8 million in Q1 2026 to a low of $187.4 million in Q2 2024.
• A 3-year average of $256.1 million and a median of $246.4 million in 2024 frame the typical range for Current Deferred Revenue.
• Across the five-year window, Current Deferred Revenue jumped 38.24% in 2025 and surged 56.8% in 2026, its largest moves.
• Tracing HNGE's Current Deferred Revenue over 3 years: stood at $217.6 million in 2024, then jumped by 38.24% to $300.9 million in 2025, then climbed by 13.27% to $340.8 million in 2026.
• Business Quant data shows HNGE's Current Deferred Revenue at $340.8 million in Q1 2026, $300.9 million in Q4 2025, and $299.7 million in Q3 2025.